The SIOG Blog provides a broad variety of articles, ranging from expert opinions on specific aspects of the care of older individuals with cancer to more practical views on the role of oncogeriatrics in an ageing world.
The blog will be updated regularly and we welcome the contribution of our members.
INTERVIEW WITH THE AUTHOR – THE ECOOL STUDY
BRIEF DESCRIPTION OF THE AUTHORS: Angela Macias Valle PhD student [...]
Introducing the Latest GerOnTe Project Newsletter: Enhancing Well-being for Older Multimorbid Patients
GerOnTe is a 5-year research and innovation project (April 2021 [...]
Medication assessment in older adults with cancer – Current practices in clinical pharmacy
INTRODUCTION Clinical pharmacists, especially those working in oncology settings, play [...]
Interview with the Author – The Climb Study: Endocrine Therapy in Older Women with Breast Cancer
The CLIMB Study Breast cancer remains a significant health concern [...]
5 minutes with the author: The impact of the Modified Frailty Index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy
September 5, 2022 Is the Modified Frailty [...]
Just in case your patient cannot answer your questions: Screening for severe sarcopenia-related functional impairments with the proxy-reported version of the SARC-F questionnaire
June 20, 2022 Journal of Cachexia, Sarcopenia, [...]
5 minutes with the author of international trends in cancer incidence in middle-aged and older adults in 44 countries
March 22, 2022 Journal of Geriatric Oncology [...]
Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trials
Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.
Prostate Cancer Radiotherapy Documentary
"A decade of reporting on SIOG Annual Conferences and the deliberations of the prostate cancer Task Force gave me a good understanding of what to expect when I was diagnosed with the tumour. Even so, the change from elderly writer to elderly patient required some adjustment!" - Rob Stepney
Ageism: worth to talk about
The term, “ageism” was created in 1969 by the gerontologist Robert Butler to define age-related prejudice, covering all age groups.
The challenges of treating head and neck cancer in the older population
The number of patients with cancer aged 65 years and older will increase in next several decades. Approximately 25% of patients with head and neck cancer (HNC) are aged 70 years and older.
The Challenges of Implementing a Geriatric Oncology Service in a Developing Country like Brazil
At present, older adults are the majority of the cancer population, including low and middle-income countries. They suffer in a disproportionate manner from inequity...
Pre-Habilitation in Hepatobiliary and Pancreatic Malignancies
Patients undergoing major cancer interventions such as surgical, chemotherapy, radiotherapy, and immunotherapy are prone to the adverse effects of their cancer, as well as side effects of cancer treatments.
Know Your Bias
In 1847 Hungarian physician Ignaz Semmelweis clearly demonstrated that hand washing prevented deaths of surgical patients.
Value of an internship/visit to other institutes, sharing on one’s own experiences
Geriatric oncology is gaining increasing momentum as a subspecialty ensuring comprehensive care for older adults with cancer.
Training in (geriatric) oncology in COVID-times
The COVID 19 pandemic has had an unprecedented impact on many medically compromised individuals including cancer patients.
Immunotherapy in older patients with cancer
Our immune system is designed to protect us not just from infections but also from cancer. In fact, the immune system has been recognized as one of the hallmarks of cancer with intense research worldwide.